OSSIO Gains FDA Clearance for OSSIOfiber Hammertoe Fixation
OSSIO was granted FDA 510(k) clearance to market the OSSIOfiber® Hammertoe Fixation system....
Mar 12, 2020,
OSSIO Gains FDA Clearance for OSSIOfiber Hammertoe Fixation
DePuy Synthes Announces CE Mark for BI-MENTUM Dual Mobility Hip
DePuy Synthes has been informed of CE Mark approval for the BI-MENTUM™ Dual Mobility hip for patients with a higher dislocation risk....
Mar 12, 2020,
Arthrosurface OVO with Inlay Glenoid Total Shoulder Study Update
Study results indicate that use of Arthrosurface's OVO® with Inlay Glenoid Shoulder Arthroplasty System to treat glenohumeral OA yielded improved clinical...
Mar 12, 2020,
SI-BONE Double Digit Growth Fueled by Reimbursement Wins
Driven by additional favorable reimbursement decisions from payers and an expanding sales force, SI-BONE grew 22% in 2019....
Mar 12, 2020,
NuVasive Attrax Putty Study Results
Study results support the use of NuVasive's Attrax® Putty as a standalone bone graft substitute for autograft in instrumented thoracolumbar...
Mar 10, 2020,
OrthoPediatrics Launches Large Fragment Cannulated Screw in U.S.
OrthoPediatrics commenced limited U.S. launch of the Large Fragment Cannulated Screw....
Mar 10, 2020,
AAOS Cancels 2020 Annual Meeting in Face of COVID-19 Concerns
The 2020 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) is canceled due to the ongoing spread of...
Mar 10, 2020,
Orthopediatrics On Fast Track To $100 Million With Double Digit Growth
Expansion of its sales force and portfolio drove Orthopediatrics to 26% growth in 2019 as it climbs toward the $100...
Mar 09, 2020,
ATEC Outperforms Expectations With 24% Growth In 2019
With 12 new product launches and improvement across all major growth metrics, ATEC drove 24% growth in 2019 as it...
Mar 09, 2020,
Gramercy Extremity Orthopedics Secures $1 Million Revolving Line of Credit
Gramercy Extremity Orthopedics entered into a new agreement for a $1 million revolving line of credit....
Mar 09, 2020,
Loading new posts...
No more posts
